Sofamor Danek tissue resector
This article was originally published in The Gray Sheet
Executive Summary
Designed to remove bulging or herniated discs "in a minimally invasive manner" will be launched this month, President and CEO Ron Pickard told investors at the recent Hambrecht & Quist life sciences conference in San Francisco. In addition, the firm's disc spacer is scheduled to enter European clinicals this year, with an investigational device exemption expected to be filed with FDA later in 1994. The firm also hopes to start European clinicals for its prosthetic disc late this year, with an IDE submission anticipated in 1995